Xeris Biopharma Holdings (XERS) Return on Capital Employed Growth (1y) (2022 - 2026)
Xeris Biopharma Holdings (XERS) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.88 Bn | 32.14 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.64 Bn | 30.70 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.04 Bn | 20.88 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.37 Bn | 18.57 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.45 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 1,195.00 |
| 10 | Xeris Biopharma Holdings | 1.42 Bn | 1.31 Bn | 72.55 Mn | 2,337.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,337.00 |
| Dec 31, 2025 | 2,449.00 |
| Sep 30, 2025 | 2,334.00 |
| Jun 30, 2025 | 1,010.00 |
| Mar 31, 2025 | 750.00 |
| Dec 31, 2024 | 395.00 |
| Sep 30, 2024 | 127.00 |
| Jun 30, 2024 | 1,138.00 |
| Mar 31, 2024 | 876.00 |
| Dec 31, 2023 | 1,362.00 |
| Sep 30, 2023 | 2,703.00 |
| Jun 30, 2023 | 2,001.00 |
| Mar 31, 2023 | 2,380.00 |
| Dec 31, 2022 | 5,023.00 |